In the News

February 20, 2024 | Pratt School of Engineering

Harnessing Skin Cancer Genes to Heal Hearts

January 30, 2024 | Department of Molecular Genetics & Microbiology

Dr. Adrianna San Roman Joins MGM Faculty

January 22, 2024

Gersbach part of panel discussion at Global Healthspan Summit

CAGT Director Charlie Gersbach was part of a panel discussion, "Growing a Healthier Future Together," at the Global Healthspan Summit.  Watch the discussion on YouTube

January 9, 2024 | Duke School of Medicine

Shah Named Associate Dean for Translational Research

In this role, Shah will serve in an expanded capacity from her previous role as associate dean of genomics.

artistic rendering of virus

December 11, 2023 | Genetic Engineering & Biotechnology News

Rhapsody in B: Tune Therapeutics Presents Data for Hepatitis B Epigenetic Silencer

Emerging from stealth in 2021, Tune Therapeutics is one of the leaders in the rapidly growing arena of epigenome editing. The scientific co-founders are Charles Gersbach, PhD, and Fyodor Urnov, PhD. GEN Edge recently conducted an exclusive interview with Urnov, during which he spoke at length about Tune’s founding and philosophy.

Charlie Gersbach

November 17, 2023 | Duke Research Blog

Gersbach among those on Clarivate's Most Highly Cited Scientists for 2023

Gerbach is one of the most highly cited authors in Biology & Biochemistry

artistic rendering of CRISPR enhanced T-cells attacking tumor

November 9, 2023 | Pratt School of Engineering

Master Regulator of the Dark Genome Greatly Improves Cancer T-Cell Therapy

A CRISPR-based platform identified many genes that could potentially improve T-cell therapies for cancer treatment

November 2, 2023

CAGT Travel Award Winners: Mia Hamilton & Lauren Hong

  The Center for Advanced Genomic Technologies (CAGT) awarded two travel awards to current trainees. These awards will help trainees seek external opportunities to extend the scope and impact of their research by learning new methods or technologies and bring that expertise [...]

Maria Ciofani

October 16, 2023 | Duke School of Medicine

Surprise Discovery Reveals Key Factor in Multiple Sclerosis

Researchers at Duke University School of Medicine studying multiple sclerosis made an unexpected discovery that could reshape the understanding of MS treatments.

October 2, 2023 | Duke School of Medicine

Using Gene Therapy to Treat Brain Disease

Doug Marchuk and Aravind Asokan have been awarded a three-year $1.9 million grant from the Department of Defense to develop less invasive treatment options for familial cerebral cavernous malformations (CCM).

boris kantor

July 20, 2023 | Cision PR Newswire

CRISPR/Gene Editing Technology Creates New Treatment Possibilities for Alzheimer's Disease

Boris Kantor and Ornit Chiba-Falek described an epigenome therapy platform based on CRISPR/dCas9-editing strategy intended to reduce APOE-e4 at the Alzheimer's Association International Conference

July 10, 2023

CAGT Dedicating to Mentoring

The genomics field at Duke is thriving because of the highly collaborative, interdisciplinary research environment that spans basic, translational, and clinical research. Mentoring future researchers is a key priority at the center. CAGT faculty are committed to training, [...]

yarui diao

June 29, 2023 | Duke School of Medicine

Muscle Stem Cells: Should I Stay or Should I Go?

Our bodies have the remarkable ability to heal from these injuries, thanks to muscle stem cells.

April 26, 2023

Cameron Kim wins Klein Family Distinguished Teaching Award

Klein Family Distinguished Teaching Award Cameron Kim, PhD Recognizes an outstanding educator. These faculty inspire students to learn and apply knowledge, engage students in the classroom and share their love of engineering. Cameron is passionate about training the next [...]

medical research science building 2 or MSRB2

March 30, 2023 | Duke School of Medicine

Collaboration Seeks Genetic Clues to Chronic Lung Disease

Idiopathic pulmonary fibrosis (IPF) is a disease that causes scarring on the lungs. Over time, as more scarring occurs, patients experience decreased lung function and difficulty breathing. Once diagnosed, most patients die within five years.

Raluca Gordan

March 30, 2023 | Duke School of Medicine

Study Reveals How UV Radiation May Drive Melanoma

Raluca Gordân, PhD, and team investigated how transcription factors may affect the production of genetic mutations, or mutagenesis, by binding to the wrong sites after being exposed to ultraviolet (UV) radiation.

boris kantor headshot with duke arches behind him

March 27, 2023 | Duke Today

Alumnus Ariel Kantor Cited by Forbes Europe in 30 Under 30 List

Duke alumnus, former member of the Gersbach lab, and Rhodes Scholar Ariel Kantor was selected for Forbes Europe's latest "30 under 30" — an annual listing of top young innovators, entrepreneurs and world changers.

Aravind Asokan

February 1, 2023 | Duke OTC

Asokan named Global Scholar

Charlie Gersbach

December 15, 2022 | Duke Today

Gersbach Elected to National Academy of Inventors

ost-mortem examination of a mouse heart shows a clear delineation in blue where TREE gene enhancer sensed and responded to tissue damage of a heart attack

December 13, 2022 | Duke Today

Gene Therapy for Heart Attacks in Mice Just Got More Precise

A team of Duke scientists studying how other animals regrow damaged tissues has made an important step toward controlling at least one part of the regenerative machinery with that kind of precision.

Aravind Asokan

November 30, 2022 | Duke School of Medicine

Aravind Asokan to Lead Partnership with Danaher Corporation to Accelerate Gene Therapy Breakthroughs 

Aravind Asokan will lead a new strategic partnership with Danaher Corporation to form the first Danaher Beacon for Gene Therapy Innovation, a new initiative designed to access breakthrough science to create technologies and applications that will improve human health.

Charlie Gersbach

November 16, 2022 | Duke Research Blog

Gersbach Among Most Cited Scientists

Gersbach is one of 30 Duke faculty to make this year's list

Pages